Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Yamanouchi discovers novel class of potent, nonsteroidal human 5alpha-reductase inhibitors

Nov. 29, 2000

R&D at Sanofi-Synthelabo leads to identification of potent PDE5 inhibitors

Nov. 27, 2000

Novel steroidal aromatase inhibitor TZA-2237 tested in dog models of BPH

Nov. 27, 2000

Sildenafil tested in patients with LVD

Nov. 24, 2000

Potential new treatments for urinary incontinence described by Sanofi-Synthelabo

Nov. 20, 2000

Triarylimidazoles synthesized at SmithKline Beecham active as inhibitors of TGF-beta signaling

Nov. 20, 2000

Team from Roche Bioscience identifies new target for the treatment of overactive bladder

Nov. 17, 2000

Research at Neurogen leads to identification of new B2 receptor modulators

Nov. 13, 2000

Investigational drug for ED discovered by Fujisawa now licensed to TAP

Nov. 10, 2000

Phase II trial results for Alprox-TD in ED announced by NexMed

Nov. 8, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...